with best-in-class real-world evidence
Behavioral health needs better evidence to drive decision-making. There is currently no standardized way to measure symptoms or quality of care for behavioral health conditions, making innovation in the field difficult to achieve.
We know that real-world data and analytics can revolutionize the behavioral health landscape by unlocking new and much-needed evidence to guide decisions for successful treatment development, efficient care delivery, and improved patient outcomes.
That's why we've built the field's largest, most robust source of clinical data for real-world data and a uniquely powerful evidence engine. We're ready to set the standard for behavioral health.
GET STARTED
We have captured and mapped de-identified data from patient electronic health records across the U.S. to create NeuroBlu Data, a single source of truth that reflects how behavioral health care is delivered. This data powers NeuroBlu Analytics, Holmusk's evidence engine that enables researchers to build patient cohorts, conduct studies at an unprecedented level of granularity, and generate impactful evidence.
patients
geographically-diverse health systems
years of longitudinal data
Follow patients over time with over 20 years of data, spanning inpatient and outpatient sites, including hospitals, emergency rooms, and community psychiatry clinics.
Conduct observational studies with data that are curated and ready to address your most challenging research questions.
Track patient functioning and outcomes and compare different groups of patients with standardized quantitative outcome measures.
8.8M+ patients
3.7M+ patients
3.1M+ patients
1.4M+ patients
393K+ patients
379K+ patients
307K+ patients
298K+ patients
263K+ patients
158K+ patients
NeuroBlu Data is enriched through the application of natural language processing models—the first to be developed specifically for behavioral health.
These models extract important information from unstructured clinical notes within the electronic health record and transform it into standardized measures, adding valuable context to research by making more fit-for-purpose data available than ever before.
Holmusk offers a range of digital solutions aimed at harnessing real-world data to improve behavioral health. Whether you're a researcher, a clinician, or a payer, we have a data-driven solution for your challenges.
Analytics software
Access insights in just a few clicks with our user-friendly data analytics software, complete with no-code analytics capabilities and pre-designed study templates so you can get the answers you need faster.
Care management software
Leverage rich, structured real-world data from providers’ electronic health records to reduce avoidable cost of care, improve care operations and quality of care.
Clinical expertise
Conduct analysis within NeuroBlu Analytics alongside our team of clinical and data science experts, who will guide you through the design and execution of an end-to-end study tailored specifically to your organization's needs.
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
Make informed, data-driven decisions with our Management and Supervision Tool (MaST), a clinical decision support tool used in the U.K. that leverages data visualization and predictive analytics to prioritize individuals at risk of crisis and improve caseload management.
Seamlessly integrate measurement-based care with an electronic health record designed specifically for data capture and visualization within psychiatry practices and other mental health clinics.
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
•Substance use disorders: 255k+ patients
•Major depressive disorder: 251k+ patients
•Bipolar disorder: 134k+ patients
•Attention-deficit/hyperactivity disorder: 82k+ patients
•Post-traumatic stress disorder: 63k+ patients
•Schizoaffective disorder: 34k+ patients
•Schizophrenia: 33k+ patients
•Borderline personality disorder: 19k+ patients
•Autism spectrum disorder: 16k+ patients
LEARN MORE
Our solutions have been leveraged by a range of stakeholders who share our vision that better evidence can vastly improve behavioral health.
See How We Collaborate
Explore recent peer-reviewed publications and conference abstracts that leverage NeuroBlu Data to share new real-world evidence with the scientific community.
Read More
Catch up on the latest company announcements, including news about novel collaborations, innovative projects, awards, and more.
Read More
Curious about the latest developments in real-world evidence and mental health? Check out our blog, the Hol Picture, where leaders from across Holmusk share thoughts.
Read More
We’d love for you to come along on the journey of improving behavioral health with better evidence.
Curious about what’s happening in the real-world evidence space? Check out our blog, the Hol Picture, where we share takeaways from recent talks and weigh in on news involving real-world evidence and behavioral health.
Explore recent peer-reviewed publications and conference abstracts that leveraged NeuroBlu data to share new real-world evidence with the scientific community.
Read More
Catch up on the latest company announcements, including news about novel collaborations, innovative projects, awards, and more.
Read More
Curious about the latest developments in real-world evidence and mental health? Check out our blog, the Hol Picture, where leaders from across Holmusk share thoughts.
Read More
We’re making fast strides toward a reimagined future for behavioral health, and we’d love for you to come along on our journey.